Tag: phase II PHAROS trial
Pierre Fabre Laboratories receives CHMP positive opinion for Braftovi in combination...
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending the approval of Braftovi (encorafenib)...